AwardedSpainGoods€353,000
CBAM 494/2025 JANSSEN CILAG/04
- Published
- Published 19 May 2026
Overview
PNAMSP 126/2025 ACUERDO MARCO UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA SUM.TRACTO SUCESIVO Y PRECIO U. DEL MEDICAMENTO EXCLUSIVO CILTACABTAGEN AUTOLEUCEL 3,20MILL CELULAS/INYECTABLE IV 30 ML-Capac:30;Forma farmacéutica INYECTABLE IV(DENOMINACIÓN COMERCIAL CARVYKTI 3,2×10 6-1×108 CELULAS DISPERSION PARA PERFUSION),PARA HOSP.U.VIRG.ROCÍO,REINA SOFÍA Y REGIONAL,CENTROS ADSCRITOS A CPC DE SEVILLA,CÓRDOBA Y MÁLAGA,MEDIANTE PROC.NEG.SIN PUBLIC.CON EMPRESA JANSSEN-CILAG,SA,TRAMITE URGENTE
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €353,000
- Procedure
- Direct
- Published
- 19 May 2026
Pharmaceutical products
Award outcome
- Awarded value
- €353,000
- Award date
- 12 February 2026
- Contract period
- — → 26 September 2027
- JANSSEN-CILAG, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
19 May 2026
Contracting authority
Servicio Andaluz de Salud. Hospital Universitario de Málaga
Procuring entityMálaga, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.